Reaction
Laziness reporting signals
As of the last recalculation, Laziness appears in 1,691 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is RELUGOLIX (PRR 21.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Relugolix | 40 | 21.4 | 21.4 |
| Ribociclib | 24 | 9.5 | 9.5 |
| Cenobamate | 6 | 8.9 | 8.9 |
| Minoxidil Foam 5% (Womens) | 20 | 7.5 | 7.5 |
| Brexpiprazole | 10 | 7.5 | 7.5 |
| Enzalutamide | 34 | 7.2 | 7.2 |
| Sacubitril And Valsartan | 59 | 6.4 | 6.4 |
| Ravulizumab | 7 | 6.4 | 6.4 |
| Atomoxetine Hydrochloride | 12 | 6.2 | 6.2 |
| Amphetamine | 4 | 6.0 | 6.0 |
| Nilotinib | 14 | 5.9 | 5.9 |
| Minoxidil | 21 | 5.8 | 5.8 |
| Siponimod | 4 | 5.5 | 5.5 |
| Brivaracetam | 4 | 5.5 | 5.5 |
| Varenicline Tartrate | 35 | 5.5 | 5.5 |
| Lurasidone Hydrochloride | 9 | 5.3 | 5.3 |
| Orlistat | 11 | 5.3 | 5.3 |
| Lacosamide | 15 | 5.0 | 5.0 |
| Romiplostim | 6 | 4.9 | 4.9 |
| Eltrombopag Olamine | 9 | 4.8 | 4.8 |
| Naltrexone | 12 | 4.8 | 4.8 |
| Selinexor | 3 | 4.3 | 4.3 |
| Rucaparib | 3 | 4.2 | 4.2 |
| Ofatumumab | 10 | 3.7 | 3.7 |
| Pirfenidone | 12 | 3.6 | 3.6 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 3 | 3.5 | 3.5 |
| Paliperidone Palmitate | 9 | 3.5 | 3.5 |
| Glecaprevir And Pibrentasvir | 3 | 3.4 | 3.4 |
| Apalutamide | 3 | 3.1 | 3.1 |
| Velpatasvir And Sofosbuvir | 3 | 2.9 | 2.9 |
| Dornase Alfa | 4 | 2.5 | 2.5 |
| Valbenazine | 4 | 2.0 | 2.0 |
| Voxelotor | 3 | 1.6 | 1.6 |